Pratap Neelakantan, David Marin, Mike Laffan, John Goldman, Jane Apperley, and Dragana Milojkovic. 2012. “Platelet Dysfunction Associated With Ponatinib, a New Pan BCR-ABL Inhibitor With Efficacy for Chronic Myeloid Leukemia Resistant to Multiple Tyrosine Kinase Inhibitor Therapy”. Haematologica 97 (9). Pavia, Italy, 1444-44. https://doi.org/10.3324/haematol.2012.064618.